Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Adult Hodgkin lymphoma AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Prognosis
172 results:

  • 1. An evaluation of glofitamab, the first fixed-duration bispecific antibody for relapsed or refractory large B-cell lymphomas.
    Polgarova K; Trneny M
    Expert Opin Biol Ther; 2024; 24(1-2):7-13. PubMed ID: 38305755
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical and pathological characteristics and prognosis analysis of gray zone lymphoma].
    Liu SZ; Zong XP; Cai WZ; He HJ; Ma ZX; Li JQ; Li CX; Wu DP
    Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(1):69-73. PubMed ID: 38178771
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Pharmacological characteristics and clinical outcomes of Epcoritamab (recombinant) (Epkinly
    Takaura K; Ando H; Ganoza ER
    Nihon Yakurigaku Zasshi; 2024; 159(1):61-68. PubMed ID: 38171842
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma.
    Yang X; Luo C; Qian J; Huang X; Zhang J; Wang J; Luo C; Qin X; Li B; Chen J
    Front Immunol; 2023; 14():1219872. PubMed ID: 37736096
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. lymphomas of Central Nervous System.
    Yokogami K; Azuma M; Takeshima H; Hirai T
    Adv Exp Med Biol; 2023; 1405():527-543. PubMed ID: 37452952
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Gray zone lymphoma: five cases report and literature review].
    Zou HS; Zhang HJ; Liu HM; Huang WY; Liu W; Lyu R; Wang TY; Sui WW; Fu MW; Wang Q; Qiu LG; Zou DH
    Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):242-246. PubMed ID: 37356987
    [No Abstract]    [Full Text] [Related]  

  • 7. Retrospective characterization of nodal marginal zone lymphoma.
    Stuver R; Drill E; Qualls D; Okwali M; Lee Batlevi C; Caron PC; Dogan A; Epstein-Peterson ZD; Falchi L; Hamlin PA; Horwitz SM; Imber BS; Intlekofer AM; Johnson WT; Khan N; Kumar A; Lahoud OB; Lue JK; Matasar MJ; Moskowitz AJ; Noy A; Owens CN; Palomba ML; Schöder H; Vardhana SA; Yahalom J; Zelenetz AD; Salles G; Straus DJ
    Blood Adv; 2023 Sep; 7(17):4838-4847. PubMed ID: 37307213
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cellular and humoral immunotherapy in children, adolescents and young adults with non-hodgkin lymphoma.
    Chu Y; Gardenswartz A; Diorio C; Marks LJ; Lowe E; Teachey DT; Cairo MS
    Best Pract Res Clin Haematol; 2023 Mar; 36(1):101442. PubMed ID: 36907635
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diffuse large B cell lymphoma CD5-positive arising in an immune deficiency and immune dysregulation setting: A case report and brief review of the literature.
    Cristian M; Baz RA; Stoica AG; Așchie M; Ghinea MM; Deacu M; Boșoteanu M; Mitroi AF; Dobrin N; Iordache IE; Bălțătescu GI
    Medicine (Baltimore); 2023 Feb; 102(8):e33083. PubMed ID: 36827036
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Large B-cell lymphoma with IRF4 gene rearrangements: Differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients.
    Berg HE; Peterson JF; Lee HE; McPhail ED
    Hum Pathol; 2023 Jan; 131():108-115. PubMed ID: 36470475
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Standard treatment and future perspectives for follicular lymphoma].
    Kameoka Y
    Rinsho Ketsueki; 2022; 63(9):1135-1144. PubMed ID: 36198539
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. FOXP3+/CD68+ ratio within the tumor microenvironment may serve as a potential prognostic factor in classical hodgkin lymphoma.
    Zawati I; Adouni O; Manai M; Nagara M; Tacam M; Reduzzi C; Gamoudi A; Manai M
    Hum Immunol; 2022 Dec; 83(12):843-856. PubMed ID: 36068099
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Nodular lymphocyte predominant hodgkin lymphoma (paragranuloma of Poppema) in children: Case report, review of the literature and treatment].
    Wilgenhof K; Théate I; Devalck C; Forsyth R; Dehou MF
    Ann Pathol; 2023 Jan; 43(1):39-44. PubMed ID: 36008237
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell lymphoma.
    Karakatsanis SJ; Bouzani M; Symeonidis A; Angelopoulou MK; Papageorgiou SG; Michail M; Gainaru G; Kourti G; Sachanas S; Kalpadakis C; Katodritou E; Leonidopoulou T; Kotsianidis I; Hatzimichael E; Kotsopoulou M; Dimou M; Variamis E; Boutsis D; Kanellias N; Dimopoulou MN; Michali E; Karianakis G; Tsirkinidis P; Vadikolia C; Poziopoulos C; Pigaditou A; Vrakidou E; Economopoulos T; Kyriazopoulou L; Siakantaris MP; Kyrtsonis MC; Anargyrou K; Papaioannou M; Hatjiharissi E; Vervessou E; Tsirogianni M; Palassopoulou M; Stefanoudaki E; Zikos P; Tsirigotis P; Tsourouflis G; Assimakopoulou T; Verrou E; Papadaki H; Lampropoulou P; Dimopoulos MA; Pappa V; Konstantopoulos K; Karmiris T; Roussou P; Panayiotidis P; Pangalis GA; Vassilakopoulos TP;
    In Vivo; 2022; 36(3):1302-1315. PubMed ID: 35478115
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pathologically complete remission to combination of invariant NK T cells and anti-cd20 antibody in a refractory HIV+ diffuse large B-cell lymphoma patient.
    Wang J; Zhang R; Ding X; Jin Y; Qin R; Xia B; Liao Q; Hu H; Song W; Wang Z; Zhang X; Xu J
    Immunotherapy; 2022 Jun; 14(8):599-607. PubMed ID: 35443802
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. CD19 or cd20 CAR T Cell Therapy Demonstrates Durable Antitumor Efficacy in Patients with Central Nervous System lymphoma.
    Liu R; Cheng Q; Kang L; Wang E; Li Y; Zhang J; Xiao H; Zhang Y; Chu L; Chen X; Zhang C; Tan J; Xu N; Li M; Yu L; Li X
    Hum Gene Ther; 2022 Mar; 33(5-6):318-329. PubMed ID: 35152726
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Blastoid variant of mantle cell lymphoma in palatine tonsil.
    Valente VB; de Castro TF; Takamiya AS; Callestini R; Xavier-Junior JCC; Cortopassi GM; Neto SC; Collado FU; Biasoli ÉR; Miyahara GI; Bernabé DG
    Oral Oncol; 2021 Nov; 122():105552. PubMed ID: 34610523
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Rare Case of Cutaneous Intravascular NK/T-Cell lymphoma.
    Jia Y; Pei D; Yang X; Min W; Song L
    Clin Lab; 2021 Jul; 67(7):. PubMed ID: 34258975
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Current treatment options for nodular lymphocyte-predominant hodgkin lymphoma.
    Eichenauer DA; Engert A
    Curr Opin Oncol; 2021 Sep; 33(5):395-399. PubMed ID: 34224482
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis.
    Ren S; Cai Y; Hu S; Liu J; Zhao Y; Ding M; Chen X; Zhan L; Zhou X; Wang X
    Biochem Pharmacol; 2021 Jun; 188():114576. PubMed ID: 33930347
    [TBL] [Abstract] [Full Text] [Related]  


    of 9.